Literature DB >> 9895348

Interference of plant peroxidases with guaiac-based fecal occult blood tests is avoidable.

M A Sinatra1, D J St John, G P Young.   

Abstract

Peroxidase-rich fruits and vegetables are reputed to interfere with guaiac-based fecal occult blood tests. We added horseradish peroxidase to fecal samples and tested them with Hemoccult, Hemoccult SENSA(R), and hydrated Hemoccult. Positivity rates with Hemoccult and Hemoccult SENSA decreased rapidly as the time between smearing (preparation) and development increased, whereas they remained high with hydrated Hemoccult. For samples with added blood, positivity rates did not decrease with time. When 61 volunteers were tested on a standard restriction and on a challenge diet high in plant peroxidase, no positive results occurred during standard restriction. During the challenge diet, one volunteer was positive with Hemoccult and Hemoccult SENSA when development was delayed 24 h, and no volunteers were positive when it was delayed 48 h and 72 h. However, with hydrated Hemoccult, positives occurred in 13 of 61 volunteers at 24 h, 8 of 61 at 48 h, and 5 of 61 at 72 h. Thus, peroxidase-rich plant foods do not need to be excluded from the diet with Hemoccult and Hemoccult SENSA if development is delayed for at least 48 h after smearing. A delay of this duration will not solve the problem of plant peroxidase interference with hydrated Hemoccult.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895348

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  9 in total

Review 1.  Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Authors:  Gerald Konrad
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

2.  Use of fecal occult blood testing in hospitalized patients: results of an audit.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Lisa Kaita; Claudia Ruiz; Elaine McIntyre; Harminder Singh
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

Review 3.  Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.

Authors:  Andrea Iannone; Giuseppe Losurdo; Maria Pricci; Bruna Girardi; Antonio Massaro; Mariabeatrice Principi; Michele Barone; Enzo Ierardi; Alfredo Di Leo
Journal:  J Gastrointest Cancer       Date:  2016-06

4.  Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test.

Authors:  P Rozen; J Knaani; Z Samuel
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

Review 5.  Guaiac-based faecal occult blood tests versus faecal immunochemical tests for colorectal cancer screening in average-risk individuals.

Authors:  Esmée J Grobbee; Pieter Ha Wisse; Eline H Schreuders; Aafke van Roon; Leonie van Dam; Ann G Zauber; Iris Lansdorp-Vogelaar; Wichor Bramer; Sarah Berhane; Jonathan J Deeks; Ewout W Steyerberg; Monique E van Leerdam; Manon Cw Spaander; Ernst J Kuipers
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

6.  Use of fecal occult blood test in hospitalized patients: survey of physicians practicing in a large central Canadian health region and Canadian gastroenterologists.

Authors:  Stephen Ip; AbdulRazaq A H Sokoro; Al Buchel; Debrah Wirtzfeld; Gerald Konrad; Tunji Fatoye; Harminder Singh
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

7.  Early detection of Haemonchus contortus infection in sheep using three different faecal occult blood tests.

Authors:  A V Rodríguez; V Goldberg; H Viotti; G Ciappesoni
Journal:  Open Vet J       Date:  2015-07-11

Review 8.  Colorectal cancer screening: tests, strategies, and perspectives.

Authors:  Fabrizio Stracci; Manuel Zorzi; Grazia Grazzini
Journal:  Front Public Health       Date:  2014-10-27

9.  Evaluation of the guaiac fecal occult blood test for detection of gastrointestinal bleeding in the rhesus macaque (Macaca mulatta).

Authors:  Rachel Elizabeth Cooper; Eric Kenneth Hutchinson; Jessica Marie Izzi
Journal:  J Med Primatol       Date:  2019-11-01       Impact factor: 0.667

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.